CTD (6.25 mg) Tablet Side Effects and usage
Read about what are the CTD (6.25 mg) Tablet medicine side effects, how and when to use CTD (6.25 mg) Tablet, common indications of CTD (6.25 mg) Tablet, when not to use CTD (6.25 mg) Tablet (contra indications), manufacturer, price and generic molecules.
CTD (6.25 mg) - Chlorthalidone- Tablet is manufactured by IPCA Laboratories Ltd. and the main constituent generic drug is Chlorthalidone- 6.25 mg.
CTD (6.25 mg) Tablet Medicine Side effects and usage
disturbance hearing loss acute saline depletion, allergic manifestations, carbohydrate intolerance, impotence, postural, hypotension, jaundice, cardiac arrhythmias, fatigue.
Hypertension, oedema, toxaemia of pregnancy, prementrual tension.
Severe renal impairment or anuria.
Severe hepatic impairment, Addisons disease, preexisting hypercalcaemia, asthma, hypersensitivity, severe allergy.
Contraindicated during pregnancy and lactation.
Existing fluid and electrolyte disturbances, hepatic cirrhosis, severe heart failure, hyperuricaemia, mild to moderate renal impairment.
Elderly, monitor fluid and electrolyte balance.
Kidney or liver disease, diabetes, gout, hyperlipidaemia and ventricular extra systoles
The cost of the drug per 1 Tablet is Rs.2.9 in India as of date.
CTD (6.25 mg) Tablet mainly contains the generic formulation called as Chlorthalidone- 6.25 mg.
CTD (6.25 mg) Tablet Medicine Generics
CTD (6.25 mg) TabletManufacturer:
IPCA Laboratories Ltd.Generic Molecule:
CTD (6.25 mg) Tablet Similar Medicines List: